Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Source: Senate LDA
Improving Access To Affordable Prescription Drugs Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SCREEN Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Modernizing Drug Enforcement Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Expanding Access to Low Cost Generic Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (H.R. 5247); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Modernizing Drug Enforcement Act of 2018 (H.R. 5298) The Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 (H.R. 5202); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018; House opioids legislation discussion drafts on FDA Long-term Efficacy, FDA Misuse/Abuse, FDA Packaging and Disposal, FDA Accelerated Approval and Breakthrough Therapy Status, and FDA and International Mail; Drug importation; Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); 180-day exclusivity; Over-the-Counter Drug Safety, Innovation, and Reform Act (S. 2315); Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling.
Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Recall Unsafe Drugs Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Keeping American Jobs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Synthetic Drug Control Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FAST Generics Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
CREATES Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Ensuring Veteran Enterprise Participation in Strategic Sourcing Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Lower Drug Costs through Competition Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Lower Drug Costs through Competition Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Protecting Seniors Access to Medicare Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
SITSA Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Protecting Medicare from Executive Action Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Increasing Competition in Pharmaceuticals Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Increasing Competition in Pharmaceuticals Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
North American Energy Infrastructure Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
RACE for Children Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Affordable and Safe Prescription Drug Importation Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Improving Access To Affordable Prescription Drugs Act
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Safe and Affordable Drugs from Canada Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Safe and Affordable Drugs from Canada Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
FDA Reauthorization Act of 2017
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act.
Client: PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · Firm: COVINGTON & BURLING LLP
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Regulation of Nonprescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Synthetic Drug Control Act of 2017 (H.R. 1732); Pandemic All-Hazards Preparedness Reauthorization Act of 2017; Opioid scheduling not associated with any particular bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2017 · fourth_quarter · Q4
Regulation of Nonprescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (S. 204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Synthetic Drug Control Act of 2017 (H.R. 1732); Make America Secure and Prosperous Appropriations Act, 2018 (H.R. 3354); Anticipated Fiscal Year 2017 Senate Budget Reconciliation Bill
Drug importation; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues; Independent Payment Advisory Board - Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849); Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(H.J. Res. 51); Protecting Medicare from Executive Action Act of 2017 (S. 251); A Joint Resolution Approving the Discontinuation of the Process for Consideration and Automatic Implementation of the Annual Proposal of the Independent Medicare Advisory Board under Section 1899A of the Social Security Act(S.J. Res. 16)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2017 · third_quarter · Q3
Regulation of Nonprescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Drug importation; IPAB; Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Bayh-Dole march-in rights policy issues
Trickett Wendler Right to Try Act of 2017 (S.204); Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); Food and Drug Administration Reauthorization Act (S. 934/H.R. 2430); Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 (H.R. 2025); Medical Product Communications Act of 2017 (H.R. 1705); S. Amendment 178 to S. Con. Res. 3 (on importation of drugs from Canada); Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (H.R. 2212/S. 974); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469/H.R. 1245); RACE for Children Act (S. 456/H.R. 1231); Safe and Affordable Drugs from Canada Act of 2017 (S. 92); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018 (H.R.3268); Preserving Patient Access to Compounded Medications Act of 2017 (H.R. 2781)
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2017 · second_quarter · Q2
Regulation of Nonprescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Trickett Wendler Right to Try Act of 2017 (S.204); Biosimilar User Fee Act; Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051) and CREATES Act (S. 3056); Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act); Affordable and Safe Prescription Drug Importation Act (S. 469); RACE for Children Act (S. 456/H.R. 1231); Prescription Drug User Fee Act; Improving Access To Affordable Prescription Drugs Act (S.771/H.R. 1776); Preserve Access to Affordable Generics Act (S. 124); American Health Care Act, section Tax on prescription medications; Recall Unsafe Drugs Act of 2017 (H.R. 1108)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2017 · first_quarter · Q1
Regulation of Nonprescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2016 · fourth_quarter · Q4
Drug Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via COVINGTON & BURLING LLP
2016 · third_quarter · Q3
Drug Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE